Epinephrine, also known as adrenaline, is a hormone and a neurotransmitter. It is used as medication for treatment of allergic reactions including anaphylaxis and anaphylactic shock, as well as bronchospasm and cardiac arrest. The growing prevalence of food allergies and lifestyle changes resulting in higher risk of anaphylaxis have significantly increased demand for epinephrine. Epinephrine provides immediate relief from symptoms of severe allergic reactions such as throat swelling, difficulty breathing, low blood pressure and cardiac arrest.
The Global Epinephrine Market is estimated to be valued at US$ 2.91 Billion in 2024 and is expected to exhibit a CAGR of 11.6% over the forecast period 2024 To 2031.
Key Takeaways
Key players operating in the epinephrine market are Pfizer, Harvest Pharmaceuticals, Grand Pharma, Lincoln Medical, Ltd., Abbott Laboratories, Sanofi S.A., Mylan, Inc., ALK Abello A/S, Amedra Pharmaceuticals LLC, Impax, Emerade, Tianjin Jinyao Group, Sandoz Inc. , Bausch Health Companies Inc., Antares Pharma Inc
Epinephrine Market Growth is rising healthcare awareness and expenditure provide significant opportunities in the global epinephrine market. The increasing focus on management of chronic conditions through medication is expected to propel market growth.
North America dominates the global epinephrine market and is expected to continue its dominance over the forecast period owing to high prevalence of allergic disorders and technological advancements in the region.
Market drivers
The increasing prevalence of anaphylaxis and food allergies across the world is a key driver attributed to high market growth. According to a report by the American College of Allergy, Asthma and Immunology, anaphylaxis affects an estimated 1-2% of the population. Epinephrine's effectiveness in emergency treatment of severe allergic reactions and FDA approvals makes its demand surge in the market. Growing healthcare spending and investment in R&D to develop improved delivery methods further propels market expansion.
PEST Analysis
Political: Regulations around healthcare, availability and licensing of epinephrine products across countries. Changes in healthcare policies can impact demand.
Economic: Overall economic growth and spending on healthcare. Higher disposable incomes usually mean greater spending on medications. Recessionary pressures can negatively impact.
Social: Increasing incidence of life-threatening allergic conditions like anaphylaxis. Growing awareness about emergency treatments required. Higher social acceptability of auto-injectable epinephrine devices.
Technological: Developments in drug delivery mechanisms, availability of generic versions, innovations making auto-injectors more user-friendly. Digital health solutions assisting remote monitoring of patients.
Regions with high market concentration in terms of value
North America accounted for the largest share of the global epinephrine market by value. This is attributed to high prevalence of allergic conditions, quick adoption of new devices, strong reimbursement structure and presence of major players. Availability of generic versions further enhances access and affordability.
Fastest growing region
The Asia Pacific region is expected emerge as the fastest growing regional market over the forecast period supported by growing population afflicted with allergies, improving access to healthcare, and increasing awareness regarding epinephrine especially in China and India. Healthcare infrastructural developments also propel the regional market.
Get these Report in Japanese Language:
Get these Report in Korean Language:
About Author:
Priya Pandey is a dynamic and passionate editor with over three years of expertise in content editing and proofreading. Holding a bachelor's degree in biotechnology, Priya has a knack for making the content engaging. Her diverse portfolio includes editing documents across different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. Priya's meticulous attention to detail and commitment to excellence make her an invaluable asset in the world of content creation and refinement. (LinkedIn- https://www.linkedin.com/in/priya-pandey-8417a8173/)
